Precise weighing, automated reporting and tailored handling help pharmaceutical producers reduce waste, streamline compliance ...

The agency's new biomonitoring study will investigate PFAS exposure across the UK, providing evidence as pharmaceutical ...

The CDMO is investing $50m in additional solid-phase peptide synthesis capacity and a new commercial manufacturing line at ...

The new probes advance OGT’s transition of its CytoCell portfolio from IVDD ahead of the December 2028 Class C deadline, ...

The agreement with the UK Health Security Agency will see the Danish vaccine manufacturer supply its MVA-BN mpox and smallpox ...

VAT relief on free medicines, £1bn in new investment and revised capital allowances give pharma manufacturers progress — but ...

New rapid sterility testing capability provides eligible products with results in approximately 3–7 days through automated, ...

The Shaoxing facility will provide 250 m³ of reaction volume, with potential capacity exceeding 400 m³, as the CDMO expands ...

Pharmaceutical manufacturers already serialise medicines using 2D codes to meet regulatory requirements, but a 2D code can be so much more than a tick box for compliance, explains Ian Chapman, Strateg ...

A group of biotech founders, big pharma leaders, clinical and CMC specialists, and CDMO executives gathered at a recent ...

GmbH has launched mzassist, a vendor-neutral AI and automation control layer for multimodal mass spectrometry data processing ...

Group-wide sustainability score of 86/100 places CordenPharma among the top 5% of companies assessed by EcoVadis in the past ...